ADMA insider trading
NasdaqGM HealthcareADMA BIOLOGICS, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About ADMA BIOLOGICS, INC.
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Company website: www.admabiologics.com
ADMA insider activity at a glance
FilingIQ has scored 377 insider transactions for ADMA since Mar 13, 2015. The most recent filing in our index is dated May 12, 2026.
Across the full history, 86 open-market purchases
and 64 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ADMA insider trades is 58.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest ADMA Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading ADMA
13F funds holding ADMA
Frequently asked
- How many insider trades does FilingIQ track for ADMA?
- FilingIQ tracks 377 Form 4 insider transactions for ADMA (ADMA BIOLOGICS, INC.), covering filings from Mar 13, 2015 onwards. 36 of those were filed in the last 90 days.
- Are ADMA insiders net buyers or net sellers?
- Across the full Form 4 history for ADMA, 86 transactions (23%) were open-market purchases and 64 (17%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ADMA insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is ADMA in?
- ADMA BIOLOGICS, INC. (ADMA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $3.86B.
Methodology & sources
Every ADMA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.